Regeneron Pharmaceuticals (REGN) Return on Sales (2009 - 2026)

Regeneron Pharmaceuticals' Return on Sales history runs 18 years deep, the most recent figure standing at 0.0% for Q1 2026.

• In Q1 2026, Return on Sales changed 0.0% year-over-year to 0.0%; the TTM figure through Mar 2026 stood at 0.0% (changed 0.0% YoY), while the FY2025 annual figure was 0.0%, changed 0.0% from the prior year.
• Return on Sales was 0.0% for Q1 2026 at Regeneron Pharmaceuticals, down from 0.0% in the prior quarter.
• In the past five years, Return on Sales ranged from a high of 0.19% in Q1 2022 to a low of 0.0% in Q1 2026.
• Historically, Return on Sales has averaged 0.02% across 5 years, with a median of 0.0% in 2023.
• The sharpest annual moves came in 2022 and 2023: Return on Sales advanced 19 bps in 2022, then decreased 19 bps in 2023.
• A 5-year view of Return on Sales shows it stood at 0.12% in 2022, then slumped by 97 bps to 0.0% in 2023, then fell by 28 bps to 0.0% in 2024, then fell by 10 bps to 0.0% in 2025, then slipped by 7 bps to 0.0% in 2026.
• The last three Return on Sales figures came in at 0.0% (Q1 2026), 0.0% (Q4 2025), and 0.0% (Q3 2025), per Business Quant data.